| Not Yet Recruiting | PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP) NCT07477418 | University of Vermont | Phase 1 / Phase 2 |
| Not Yet Recruiting | CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa) NCT07153289 | University Hospital Tuebingen | Phase 1 / Phase 2 |
| Not Yet Recruiting | Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Can NCT06615830 | Prof. Dr. med. Dres. h.c. Jan Schmidt, MME | — |
| Not Yet Recruiting | Microplastics in Pancreas: Oncologic and Metabolic Impact NCT07486128 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (P NCT07504471 | Ruijin Hospital | Phase 2 |
| Not Yet Recruiting | Feasibility and Effectiveness of Three-day Discharge After Distal Pancreatectomy NCT07095621 | IRCCS San Raffaele | — |
| Recruiting | Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD NCT07139236 | Minia University | — |
| Not Yet Recruiting | The Efficacy and Safety of Trilaciclib in Bone Marrow Protection Before Chemotherapy for Advanced Bile Duct Ca NCT07160283 | The Second Affiliated Hospital of Shandong First Medical University | Phase 2 |
| Recruiting | Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumo NCT06885697 | National Cancer Institute (NCI) | Phase 1 |
| Not Yet Recruiting | 22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions NCT07012694 | Huazhong University of Science and Technology | N/A |
| Recruiting | Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3) NCT06939023 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | N/A |
| Recruiting | Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia NCT06953193 | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | N/A |
| Recruiting | Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas NCT06914674 | Fudan University | Phase 2 |
| Recruiting | Study of KRAS Neoantigen mRNA Vaccine (ABO2102) in Patients With KRAS -Mutated Solid Tumors NCT06577532 | Ruijin Hospital | EARLY_Phase 1 |
| Recruiting | Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer NCT06532617 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Not Yet Recruiting | 22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesion NCT06563232 | Huazhong University of Science and Technology | N/A |
| Completed | Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by NCT06538623 | Ruijin Hospital | Phase 2 |
| Recruiting | Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Se NCT07035587 | Yonsei University | — |
| Recruiting | A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer NCT06380816 | Cancer Research UK | Phase 1 / Phase 2 |
| Recruiting | Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatme NCT06767813 | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | Single-cell Sequencing Analysis of Resectable/Borderline Resectable Pancreatic Cancer Patients NCT06310902 | Fujian Medical University Union Hospital | — |
| Unknown | Clinical Comparative Study of Systematic Therapy Combined With MWA and Systematic Therapy for Pancreatic Cance NCT06231160 | Chinese PLA General Hospital | — |
| Recruiting | Determining Individualized Cancer Therapy in Pancreatic Cancer NCT05914987 | Medical College of Wisconsin | — |
| Unknown | Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer NCT06203613 | YiHui Guan | N/A |
| Recruiting | HTL0039732 in Participants With Advanced Solid Tumours NCT05944237 | Cancer Research UK | Phase 1 / Phase 2 |
| Recruiting | Pancreatic Cancer Screening Through the Detection of Elastase-1 Combined With Other Examinations NCT06041009 | Qilu Hospital of Shandong University | — |
| Unknown | Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer NCT05840341 | Fudan University | Phase 3 |
| Active Not Recruiting | A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors NCT05736731 | A2 Biotherapeutics Inc. | Phase 1 / Phase 2 |
| Unknown | Glucose Control Through a Bihormonal Artificial Pancreas in Patients After Total Pancreatectomy NCT06346366 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 3 |
| Recruiting | Pancreatic Cancer Detection Consortium NCT06388967 | City of Hope Medical Center | — |
| Unknown | Utidelone Injection Combined With Gemcitabine in First-line Chemotherapy for Unresectable Advanced Pancreatic NCT05795920 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Recruiting | Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Flui NCT05737953 | Zhaoshen Li | — |
| Unknown | Pre-planning Mathematical Models in EUS-guided Laser Ablation of Pancreatic Lesions NCT05549960 | Campus Bio-Medico University | N/A |
| Completed | Surufatinib Combined With TAS-102 in Third-line and Later-line Therapy of Patients With Advanced Pancreatic Ca NCT05481463 | Sun Yat-sen University | Phase 2 |
| Active Not Recruiting | A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors NCT05571839 | Seagen, a wholly owned subsidiary of Pfizer | Phase 1 |
| Completed | Diagnostic Consistency of GLIM and PG-SGA for Malnutrition in Pancreatic Cancer NCT07057895 | The First Hospital of Hebei Medical University | N/A |
| Unknown | Tislelizumab With Anlotinib and Chemotherapy for Second-line Treatment of Pancreatic Cancer NCT05681390 | First Affiliated Hospital Xi'an Jiaotong University | Phase 2 |
| Recruiting | ExoLuminate Study for Early Detection of Pancreatic Cancer NCT05625529 | Biological Dynamics | — |
| Unknown | Evaluation of the Safety and Efficacy of Esperanza Extract (PA001) NCT05587088 | Hospital Universitario San Ignacio | Phase 1 / Phase 2 |
| Completed | Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, P NCT05512377 | Boehringer Ingelheim | Phase 2 |
| Active Not Recruiting | Surufatinib Combined With Sintilimab and AG in First-line Therapy of Patients With Locally Advanced or Metasta NCT05481476 | Sun Yat-sen University | Phase 2 |
| Withdrawn | A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced NCT05465590 | Mainline Biosciences, Inc. | EARLY_Phase 1 |
| Completed | Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope NCT05429203 | Stanford University | N/A |
| Completed | Patient-derived Organoids Drug Screen in Pancreatic Cancer NCT05351983 | Prof. Dr. med. Dres. h.c. Jan Schmidt, MME | N/A |
| Completed | Open Versus Total Laparoscopic Pancreaticoduodenectomy NCT06661135 | Cairo University | N/A |
| Completed | Efficacy of the Transversus Abdominis Plane Block on Analgesia After Cephalic Duodeno-pancreatectomy NCT05546970 | University Hospital, Strasbourg, France | — |
| Terminated | Blue and Amber Light Exposure in Patients With Rectal and Pancreatic Cancer NCT06164691 | Matthew Neal MD | N/A |
| Completed | A Study of Penpulimab and Anlotinib Plus Nab-paclitaxel and Gemcitabine for Metastatic Pancreatic Cancer. NCT05493995 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 2 |
| Recruiting | Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts NCT04473794 | Johns Hopkins University | — |
| Unknown | Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea NCT05587387 | Yonsei University | — |
| Active Not Recruiting | A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer NCT05451849 | TCR2 Therapeutics | Phase 1 / Phase 2 |
| Completed | Multidimensional Prehabilitation in Pancreatic Surgery for Pancreatic and Periampullary Neoplasms NCT05225038 | Case Comprehensive Cancer Center | N/A |
| Completed | Trimodal Prehabilitation in Pancreatic Cancer Patients Urdergoing Neoadjuvant Treatment NCT05722223 | Puerta de Hierro University Hospital | N/A |
| Unknown | Correlation Between Elastic Modulus of Ultrasonic Shear Wave and Tumor Stromal Component in Pancreatic Cancer NCT05187416 | Xijing Hospital | — |
| Recruiting | Mutant KRAS G12V-specific TCR Transduced T Cell Therapy for Advanced Pancreatic Cancer NCT04146298 | Changhai Hospital | Phase 1 / Phase 2 |
| Unknown | International Pancreatic Surgery Outcomes Study - PancreasGroup.Org NCT04652271 | Royal Free Hospital NHS Foundation Trust | — |
| Unknown | Randomized Trial for Optimal Number of Passes Required for Molecular Profiling During EUS-FNB of Pancreatic Ca NCT05043532 | Orlando Health, Inc. | N/A |
| Recruiting | Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer NCT05218889 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Completed | Comparison of Two Types of Biopsy Needles for EUS-FNB in Solid Pancreatobiliary Mass Lesions NCT04975620 | University of Tehran | N/A |
| Unknown | Circulating Epigenetics in Pancreatic Surgery NCT04947696 | Rigshospitalet, Denmark | — |
| Recruiting | Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) NCT04956640 | Eli Lilly and Company | Phase 1 / Phase 2 |
| Terminated | Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation NCT04327986 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI NCT05172310 | Karolinska University Hospital | Phase 1 |
| Terminated | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic NCT04644315 | Hoffmann-La Roche | Phase 2 |
| Completed | LYNPARZA Pancreas Cancer Japan Post-Marketing Surveillance (PMS) NCT04889404 | AstraZeneca | — |
| Recruiting | Spanish Series of Patients Treated With the Radionuclide Lutetium177 NCT04949282 | Sociedad Española de Medicina Nuclear e Imagen Molecular | — |
| Completed | Prospective Study FNB, Is It Time To Abandon Cytological Assessment NCT04165018 | Baylor College of Medicine | — |
| Unknown | Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic Cancer NCT04808687 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Recruiting | Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive Methodology NCT04370574 | University Hospital, Montpellier | — |
| Completed | A Deep Learning Radiomics Model for Predicting Occult Peritoneal Metastases of Pancreatic Adenocarcinoma NCT06336694 | First Affiliated Hospital, Sun Yat-Sen University | — |
| Unknown | Evaluation of Prehabilitation as a Strategy to Minimize Surgical Risk in Pancreatic Surgery: Efficacy and Dete NCT05489419 | Hospital Clinic of Barcelona | N/A |
| Unknown | Comparsion of WT and SNP Techniques of EUS-FNB in Pancreatic Solid Mass (WESP-PSM) NCT04605042 | Ruijin Hospital | N/A |
| Unknown | Comparation Between Needles for EUS-guided Sampling of Solid Pancreatic Lesions NCT04877340 | Instituto do Cancer do Estado de São Paulo | N/A |
| Completed | Fecal and Oral Microbiota Between Pancreatic Cancer and Benign/Low-grade Malignant Tumor Patients NCT06659237 | Peking Union Medical College Hospital | — |
| Completed | Role of EUS in Detection of Liver Metastasis NCT04509492 | Mahmoud Wahba | — |
| Unknown | EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy NCT04809935 | The University of Hong Kong | Phase 4 |
| Completed | Pancreatic Anastomosis After Duodenopancreatectomy NCT04462354 | Fundación para la Investigación del Hospital Clínico de Valencia | N/A |
| Unknown | Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic Cancer NCT04289792 | Fujian Medical University Union Hospital | Phase 2 |
| Completed | A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer NCT04137289 | Boehringer Ingelheim | Phase 1 |
| Unknown | Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses NCT04709445 | Charite University, Berlin, Germany | N/A |
| Unknown | Heparin-based Wet Suction Method in EUS Fine Needle Biopsy of Solid Pancreatic Mass NCT04707560 | National Cheng-Kung University Hospital | N/A |
| Enrolling By Invitation | The Differences of Complications Between LPD(Laparoscopic Pancreaticoduodenectomy) and OPD(Open Pancreaticoduo NCT06685939 | Zhijun Bao | — |
| Unknown | Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Su NCT03838029 | Assaf-Harofeh Medical Center | Phase 2 |
| Active Not Recruiting | A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer NCT04137536 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Recruiting | UCSF PANC Cyst Registry NCT04291651 | University of California, San Francisco | — |
| Unknown | Fine Needle Biopsy of Solid Pancreatic Mass Lesions NCT04085055 | AdventHealth | N/A |
| Unknown | Construction and Evaluation of China's Advanced Pancreatic Tumor Big Data Center NCT05141656 | RenJi Hospital | — |
| Completed | Benchmarking Outcomes in Pancreatic Surgery - WhippleBenchmarks.Org NCT04053998 | Royal Free Hospital NHS Foundation Trust | — |
| Terminated | A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001) NCT03948763 | Merck Sharp & Dohme LLC | Phase 1 |
| Unknown | EUS-FNB With MOSE vs EUS-FNA With ROSE NCT03766659 | Chinese University of Hong Kong | N/A |
| Recruiting | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer NCT03977233 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Unknown | Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC NCT03634332 | Pancreatic Cancer Research Team | Phase 2 |
| Active Not Recruiting | Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy NCT03631173 | Oslo University Hospital | N/A |
| Completed | Peptide-based Immunization for Colon- and and Pancreas-carcinoma NCT03871790 | CENTOGENE GmbH Rostock | — |
| Completed | Multivisceral Resection in Distal Pancreatectomy NCT04317352 | Universidad de Extremadura | — |
| Unknown | Magnetic Compressive Technique for Pancreatic Intestinal Anastomosis NCT03780946 | First Affiliated Hospital Xi'an Jiaotong University | — |
| Recruiting | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study NCT04075305 | UMC Utrecht | — |
| Unknown | Magnetic Compressive Anastomosis for Biliojejunostomy and Pancreaticojejunostomy During Whipple's Procedure NCT03792048 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Completed | Chromogranin A as Blood Marker in Cancer Patients NCT03817866 | Brahms AG | — |
| Completed | Intermittent Suction Technique in the Diagnosis of Pancreatic Solid Lesions NCT03829748 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | N/A |
| Active Not Recruiting | 9-ING-41 in Patients With Advanced Cancers NCT03678883 | Actuate Therapeutics Inc. | Phase 2 |
| Unknown | Greater Omentum Binding to the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy NCT03752086 | Tongji Hospital | N/A |
| Completed | SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors NCT07407257 | Institute of Oncology Ljubljana | N/A |
| Completed | A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) NCT02905578 | Joseph J. Cullen | Phase 2 |
| Completed | Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma NCT03717298 | Catalysis SL | Phase 2 |
| Terminated | PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors NCT03685591 | Pfizer | Phase 1 |
| Completed | A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cance NCT03535727 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 1 / Phase 2 |
| Active Not Recruiting | Hepatic Resection for Metastatic Pancreatic Cancer NCT02892305 | Duke University | — |
| Terminated | M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma NCT03451773 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Unknown | Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms NCT03435770 | Singapore General Hospital | N/A |
| Recruiting | A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus NCT03937453 | Nuvance Health | — |
| Unknown | POstopeRative Standardization of Care: THe Implementation of Best Practice After Pancreatic Resection NCT03400280 | St. Antonius Hospital | N/A |
| Completed | Laser Tissue Welding - Distal Pancreatectomy Sealing Study NCT03147768 | Laser Tissue Welding, Inc. | Phase 1 |
| Unknown | Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic Cancer NCT03469726 | Radboud University Medical Center | N/A |
| Terminated | CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physicia NCT02900248 | CureOne | — |
| Completed | Connect Your Needle to Your Phone to Increase EUS FNA Diagnostic Yield? NCT03303352 | Carol Davila University of Medicine and Pharmacy | N/A |
| Unknown | Study of FAK (Defactinib) and PD-1 (Pembrolizumab) Inhibition in Advanced Solid Malignancies (FAK-PD1) NCT02758587 | NHS Greater Glasgow and Clyde | Phase 1 / Phase 2 |
| Completed | Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis NCT03152487 | AdventHealth | N/A |
| Withdrawn | Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectab NCT03199144 | Centre Francois Baclesse, Luxembourg | Phase 2 |
| Completed | A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers NCT03172572 | S (Sjors) Klompmaker, MD | — |
| Completed | Dendritic Cell Immunotherapy for the Patients With Pancreatic Cancer NCT03114631 | The Republican Research and Practical Center for Epidemiology and Microbiology | Phase 1 / Phase 2 |
| Unknown | FGF19 in Obstructive Cholestasis: "Unveil the Signal" NCT05718349 | Nicole Hildebrand | — |
| Completed | The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With NCT06553040 | Ege University | — |
| Completed | Comparison Between Wound Vacuum Dressing and Standard Closure to Reduce Rates of Surgical Site Infections NCT03021668 | Johns Hopkins University | N/A |
| Completed | Clinico-demographic Profile of the Patient With Pancreaticobiliary Malignancy Undergoing ERCP in a Tertiary Ca NCT06888401 | Kathmandu University School of Medical Sciences | — |
| Recruiting | Registry of Pancreatic Disease NCT03807687 | Azienda Ospedaliera Universitaria Integrata Verona | — |
| Unknown | EUS Fiducial for Pancreas Surgery NCT02863783 | University of Southern California | N/A |
| Recruiting | A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals NCT03250078 | Nuvance Health | — |
| Completed | Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP Malignancy NCT02784353 | Asan Medical Center | N/A |
| Completed | CTC Pancreatic Adenocarcinoma NCT02335151 | University of Zurich | Phase 4 |
| Completed | Comparison Between Olympus EZ Shot 3Plus 19G and EZ Shot 2 19G in EUS-guided FNB of Solid Pancreatic Masses NCT02909530 | University of Ulm | N/A |
| Completed | Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography for Malignant Distal Biliary Obstruct NCT03054987 | AdventHealth | N/A |
| Unknown | A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Muta NCT02950064 | Placon Therapeutics | Phase 1 |
| Completed | Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously NCT02810418 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Unknown | Fluorouracil and Oxaliplatin as First-line for Advanced Pancreatic Cancer NCT02896803 | Instituto do Cancer do Estado de São Paulo | Phase 2 |
| Unknown | Combined Resection vs. Separated Resection After Mobilization of Splenic Vein During Distal Pancreatectomy NCT02871804 | Wakayama Medical University | Phase 3 |
| Recruiting | EUS-guided RFA for Pancreatic Neoplasms NCT03218345 | Chinese University of Hong Kong | N/A |
| Unknown | Contrast EUS of the Pancreas NCT02863770 | University of Southern California | N/A |
| Unknown | Evaluation of Killing Activity of Expanded Natural Killer Cells From Blood in Patients With Pancreatic Cancer NCT03665571 | Asan Medical Center | — |
| Completed | Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions NCT02920944 | Seung Bae Yoon | N/A |
| Active Not Recruiting | HYPAR Trial - Hydrocortisone vs. Pasireotide in Reducing Pancreatic Surgery Complications NCT02775227 | Helsinki University Central Hospital | Phase 4 |
| Completed | Different Stapler Cartridge For Pancreatic Stump Texture To Prevent Pancreatic Fistula NCT02790333 | Yi-Ping Mou | N/A |
| Completed | Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Regi NCT02780648 | Indiana University | N/A |
| Unknown | Apatinib as Second-line Treatment of Advanced Pancreatic Cancer NCT02726854 | First Affiliated Hospital Xi'an Jiaotong University | Phase 2 |
| Unknown | Project Survival-Prospective Biomarker Discovery NCT02781012 | Pancreatic Cancer Research Team | — |
| Unknown | Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic Cancer NCT02737228 | CrystalGenomics, Inc. | Phase 1 / Phase 2 |
| Unknown | Adjuvant Gemcitabine Versus Gemcitabine With Chemoradiation in Pancreatic Adenocarcinoma With R1 Resection and NCT02754180 | Peking Union Medical College Hospital | Phase 2 |
| Withdrawn | HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma NCT02850874 | Wake Forest University Health Sciences | Phase 2 |
| Enrolling By Invitation | Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease NCT07405099 | National Taiwan University Hospital | — |
| Unknown | Dynamic Changes of Sera Immunoglobulin G4 and Interleukin-10 in the Patients of Pancreatic Cancer After Chemot NCT02654288 | Peking Union Medical College Hospital | — |
| Suspended | Acelarin First Line Randomised Pancreatic Study NCT03610100 | The Clatterbridge Cancer Centre NHS Foundation Trust | Phase 2 / Phase 3 |
| Completed | Sarcopenia is an Independent Prognostic Factor for Overall Survival in Patients With Pancreatic Adenocarcinoma NCT02977702 | Institut de Cancérologie de Lorraine | — |
| Completed | Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter NCT02591082 | RenovoRx | — |
| Withdrawn | Pancreatic Cancer Screening of High-Risk Individuals in Arkansas NCT02309632 | University of Arkansas | N/A |
| Terminated | A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in NCT02670746 | Celgene | — |
| Completed | Second-Line Oxaliplatin and Irinotecan Versus Irinotecan Alone for Gemcitabine and S-1 Refractory Pancreatic C NCT02558868 | Zhejiang University | Phase 2 |
| Completed | Rapid On-Site Evaluation (ROSE) by Endosonographer: for Whom, When and by Whom? NCT04002778 | Universidade Federal do Rio de Janeiro | N/A |
| Completed | Laparotomy, Laparoscopy, da Vinci System NCT07034495 | National Chung Hsing University | — |
| Completed | Brown Adipose Tissue Activity and Energy Metabolism in Cachexia NCT02500004 | Maastricht University Medical Center | N/A |
| Unknown | Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer NCT02450656 | The Netherlands Cancer Institute | Phase 1 / Phase 2 |
| Terminated | Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancr NCT02267707 | Celgene | Phase 1 |
| Completed | A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pan NCT02402062 | Grupo Espanol de Tumores Neuroendocrinos | Phase 2 |
| Unknown | Onco-geriatric Database of Patients With Pancreatic Cancer NCT02858141 | Institut Paoli-Calmettes | — |
| Completed | Comparison of Drug Eluting Stent and Covered Metal Stent in Malignant Biliary Obstruction (MIRA III) NCT02460432 | Taewoong Medical Co., Ltd. | N/A |
| Completed | Evaluating Weight Stability of Pancreatic Cancer Cachexia Patients NCT02400398 | Andrew Hendifar, MD | — |
| Completed | Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAP NCT02301143 | Celgene | Phase 2 |
| Completed | SBRT Pre-operatively for Pancreatic Cancer NCT02308722 | University of Oxford | Phase 1 |
| Recruiting | The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer NCT04406831 | Nuvance Health | — |
| Completed | Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients NCT02311361 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Withdrawn | Comparison Study in Pancreatic Fiducial Placement NCT02376543 | Parkview Health | N/A |
| Completed | The Effect of Satiety Gut Hormone Modulation on Appetitive Drive After Upper Gastrointestinal Surgery NCT02381249 | St. James's Hospital, Ireland | N/A |
| Completed | Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / NCT02309177 | Celgene | Phase 1 |
| Completed | Safety and Efficacy Study of Mix Vaccine in Pancreatic Carcinoma Patient NCT02338752 | Fuda Cancer Hospital, Guangzhou | Phase 1 / Phase 2 |
| Completed | Treatment of the Pancreatic Stump With Neoprene®-Based Glue After High-risk Pancreatoduodenectomy NCT03738787 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Phase 2 |
| Completed | The Canadian/US Integrative Oncology Study NCT02494037 | The Canadian College of Naturopathic Medicine | — |
| Terminated | Whipple Procedure: Standard of Care vs. Thunderbeat NCT02204124 | Washington University School of Medicine | N/A |
| Completed | Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer NCT02342847 | Celgene | — |
| Completed | Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable NCT02292745 | Foundation for Liver Research | N/A |
| Active Not Recruiting | Lipidomics, Proteomics, Micro RNAs and Volatile Organic Compounds (VOC) NCT02531607 | AdventHealth | — |
| Recruiting | Pancreatic Surgical Database NCT02871336 | Institut Paoli-Calmettes | — |
| Unknown | Follow-up Study of Complications of Acute Pancreatitis NCT02305914 | The First Affiliated Hospital of Nanchang University | — |
| Completed | A Prospective, Multi-center Trial for Reinforced Staple During Distal Pancreatectomy NCT02270554 | Wakayama Medical University | Phase 2 |
| Completed | Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients NCT02374411 | Edward Hospital | — |
| Unknown | Randomized, Controlled Trial of Endoscopic Ultrasound-Guided Bilateral Celiac Plexus Neurolysis vs Celiac Gang NCT02220062 | Samsung Medical Center | N/A |
| Completed | 22 G - 25 G SINS Trial for Pancreatic Masses NCT02424838 | AdventHealth | N/A |
| Completed | A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovaria NCT02146313 | Genentech, Inc. | Phase 1 |
| Completed | A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of NCT02154646 | Eli Lilly and Company | Phase 1 |
| Completed | The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal Surgery NCT02728921 | Region Skane | Phase 4 |
| Completed | Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic NCT01964430 | Celgene | Phase 3 |
| Completed | Feasibility of Using Ultrasound to Track Respiration Motion NCT02173353 | Medical College of Wisconsin | — |
| Unknown | Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm NCT02528526 | University of Zurich | Phase 1 / Phase 2 |
| Completed | Gemcitabine, Ascorbate, Radiation Therapy for Pancreatic Cancer, Phase I NCT01852890 | Joseph J. Cullen | Phase 1 |
| Completed | Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer NCT02043288 | Orient Europharma Co., Ltd. | Phase 3 |
| Completed | Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Ca NCT02017015 | Celgene | Phase 2 |
| Unknown | Pancreas Volume and Diabetes Status Following Pancreatectomy NCT02823678 | Florida Hospital Tampa Bay Division | — |
| Recruiting | Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma NCT01950572 | National Cancer Institute (NCI) | — |
| Completed | Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the NCT01770405 | Mauna Kea Technologies | — |
| Unknown | DNA Promoter Hypermethylation as a Blood Based Maker for Pancreatic Cancer NCT02079363 | Aalborg University Hospital | — |
| Completed | Analgesia and Pancreatic Cancer Surgery NCT01929915 | National Taiwan University Hospital | N/A |
| Completed | Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies NCT01677559 | Washington University School of Medicine | Phase 1 |
| Terminated | VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tum NCT01784861 | Washington University School of Medicine | Phase 1 / Phase 2 |
| Completed | 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients NCT01832116 | University Medical Center Groningen | Phase 1 |
| Completed | The Use of Wound Protector in Whipple's Procedure With Intrabiliary Stent NCT01836237 | University of Calgary | N/A |
| Completed | Comparative Study of 22 and 25 Gauge ProCore EUS-guided Biopsy in Pancreatic Mass NCT01727921 | Samsung Medical Center | N/A |
| Completed | Needle-based Confocal Endomicroscopy Examination of Pancreatic Masse NCT01734967 | Herlev Hospital | N/A |
| Completed | Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy NCT01731821 | Fudan University | Phase 3 |
| Terminated | Gemcitabine and CT-011 for Resected Pancreatic Cancer NCT01313416 | Augusta University | Phase 2 |
| Terminated | Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer NCT01515046 | Joseph J. Cullen | Phase 2 |
| Unknown | Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cys NCT01563133 | Mauna Kea Technologies | N/A |
| Completed | FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcin NCT01413022 | Washington University School of Medicine | Phase 1 |
| Unknown | Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy NCT01695447 | TingBo Liang | N/A |
| Unknown | Extracolonic Findings on Computed Tomography (CT) Colonography NCT01465425 | American College of Radiology Imaging Network | — |
| Terminated | Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin NCT01434459 | Emory University | Phase 1 |
| Completed | FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma NCT01383538 | Andrew Ko | Phase 1 |
| Unknown | Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer NCT01372735 | University Hospital Heidelberg | Phase 1 / Phase 2 |
| Terminated | Ketogenic Diet With Concurrent Chemoradiation for Pancreatic Cancer NCT01419483 | University of Iowa | N/A |
| Completed | Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy NCT01384253 | Orano Med LLC | Phase 1 |
| Completed | Early (4 Days) Versus Standard Drainage of the Abdominal Cavity After Pancreaticoduodenectomy NCT01368094 | Centre Hospitalier Universitaire, Amiens | N/A |
| Completed | On-site Cytopathology EUS-FNA NCT01386931 | University of Colorado, Denver | — |
| Completed | SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma NCT01362790 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Combination With Gemcitabine in Advanced Pancreatic Cancer NCT01251640 | Bayer | Phase 1 / Phase 2 |
| Completed | Safety and Feasibility Study of Enhanced Recovery in Pancreaticoduodenectomy NCT01759706 | Università Vita-Salute San Raffaele | N/A |
| Terminated | Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision NCT01188109 | Emory University | Phase 2 |
| Completed | Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer NCT01121848 | Sanofi | Phase 3 |
| Completed | Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma NCT01161186 | University of California, San Francisco | Phase 1 |
| Completed | A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma NCT01166490 | Seagen Inc. | Phase 1 |
| Completed | Textbook Outcome as a Composite Outcome Measure in Laparoscopic Pancreaticoduodenectomy NCT05616403 | Tongji Hospital | — |
| Withdrawn | Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms NCT01057355 | Mayo Clinic | Phase 1 |
| Completed | The Results of Pancreatic Operations After the Implementation of Multidisciplinary Team Conference (MDT): NCT04237441 | Rigshospitalet, Denmark | — |
| Completed | A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic Cancer NCT01049880 | Joseph J. Cullen | Phase 1 |
| Completed | A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer NCT01019382 | University Hospitals, Leicester | Phase 2 |
| Completed | Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia NCT00985777 | H. Lee Moffitt Cancer Center and Research Institute | Phase 1 |
| Completed | Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer NCT00711997 | Anchiano Therapeutics Israel Ltd. | Phase 1 / Phase 2 |
| Unknown | Evaluation of Isolated Roux-en-Y Reconstruction After Pancreaticoduodenectomy NCT00915863 | Wakayama Medical University | N/A |
| Terminated | Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer NCT01086332 | University of Iowa | Phase 1 |
| Completed | RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction NCT00980889 | Stockholm South General Hospital | Phase 4 |
| Completed | A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors NCT00841191 | Centocor, Inc. | Phase 1 / Phase 2 |
| Terminated | Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic Radiosurgery NCT00833859 | H. Lee Moffitt Cancer Center and Research Institute | Phase 2 |
| Completed | A Study for Participants With Pancreatic Cancer NCT00839332 | Eli Lilly and Company | Phase 1 / Phase 2 |
| Terminated | Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer NCT00732082 | Washington University School of Medicine | Phase 1 |
| Withdrawn | Strength Training on Pancreatic Cancer NCT01395563 | German Cancer Research Center | N/A |
| Completed | Study of PEP02 as a Second Line Therapy for Metastatic Pancreatic Cancer NCT00813163 | PharmaEngine | Phase 2 |
| Terminated | Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumor NCT01215578 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer NCT00637247 | AmpliMed Corporation | Phase 2 |
| Completed | CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma NCT00634751 | University of Wisconsin, Madison | Phase 1 / Phase 2 |
| Completed | Impact of Microparticles on Postoperative Complications in Surgical Patients NCT00677781 | University of Bern | — |
| Completed | A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally NCT00558207 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | Phase 2 |
| Completed | The Prognostic Impact of Extracapsular Lymph Node Involvement in Ductal Pancreatic Adenocarcinoma NCT00644254 | KU Leuven | — |
| Unknown | Expression of Inflammatory Proteins in Pancreatic Cancer NCT00551057 | University of Zurich | — |
| Terminated | Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer NCT00529113 | Biogen | Phase 1 |
| Completed | Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Ca NCT00515866 | AstraZeneca | Phase 1 |
| Terminated | Reinforced Staple Line on Leak Rate in Distal Pancreatectomy NCT01359410 | Washington University School of Medicine | N/A |
| Terminated | Dose-finding Study of BI 2536 Administered in Combination With Gemcitabine in Patients With Locally Advanced o NCT02215044 | Boehringer Ingelheim | Phase 1 |
| Withdrawn | Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer NCT00487851 | Karolinska Institutet | Phase 2 |
| Unknown | Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and Pancreas NCT00419627 | Hillel Yaffe Medical Center | — |
| Terminated | Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer NCT00417287 | Cascadian Therapeutics Inc. | Phase 2 |
| Completed | Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Trea NCT00417209 | Sanofi | Phase 3 |
| Completed | Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenoc NCT00495924 | KU Leuven | — |
| Completed | Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors NCT00385177 | Achieve Life Sciences | Phase 1 |
| Completed | Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patie NCT00710710 | Boehringer Ingelheim | Phase 2 |
| Completed | Preop Chemoradiation Resectable Pancreas NCT00336648 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemo NCT00363051 | Novartis Pharmaceuticals | Phase 2 |
| Terminated | A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduo NCT00359320 | Thomas Jefferson University | N/A |
| Completed | High Dose Somatostatin Analogues in Neuroendocrine Tumors NCT00990535 | Federico II University | Phase 2 |
| Completed | GEMOX: Oxaliplatin in Pancreatic Cancer NCT00261092 | Sanofi | Phase 2 |
| Completed | AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Can NCT00219557 | Pfizer | Phase 2 |
| Completed | Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce T NCT00844064 | Isarna Therapeutics GmbH | Phase 1 |
| Terminated | Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study NCT00100321 | National Cancer Institute (NCI) | — |
| Completed | Study of Safety and Efficacy of Glufosfamide in Combination With Gemcitabine in Cancer NCT00102752 | Threshold Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Trial of Curcumin in Advanced Pancreatic Cancer NCT00094445 | M.D. Anderson Cancer Center | Phase 2 |
| Unknown | Biliary Tissue Sampling Using a Cytology Brush or the GIUM Catheter NCT00160836 | University Hospital, Geneva | Phase 1 |
| Completed | Randomized Trial of EUS Neurolysis in Pancreas Cancer NCT00279292 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Completed | Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer NCT00242190 | University of Michigan Rogel Cancer Center | Phase 1 / Phase 2 |
| Completed | Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pan NCT00220649 | St. Luke's-Roosevelt Hospital Center | Phase 1 |
| Completed | Acupuncture For Pancreatic Cancer Pain NCT00136669 | Memorial Sloan Kettering Cancer Center | Phase 3 |
| Completed | Malignant Obstruction ZILVER Against Routine Therapy (MOZART I) NCT00196105 | Cook Group Incorporated | N/A |
| Unknown | Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer NCT00178763 | The University of Texas Health Science Center, Houston | Phase 2 |
| Completed | A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Ca NCT00060502 | Centocor, Inc. | Phase 2 |
| Completed | Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer NCT00191568 | Eli Lilly and Company | Phase 2 |
| Completed | A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancrea NCT00034827 | Pfizer | Phase 2 |
| Completed | The Efficacy and Safety of Gemcitabine in Combination With Docetaxel to Treat Pancreatic or Biliary Cancer NCT00268840 | ARCAGY/ GINECO GROUP | Phase 2 |
| Completed | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver NCT00041808 | FeRx | Phase 1 / Phase 2 |
| Completed | Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma NCT00201838 | Ohio State University Comprehensive Cancer Center | Phase 1 / Phase 2 |
| Completed | Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer NCT00041639 | Gilead Sciences | Phase 1 / Phase 2 |
| Recruiting | Institut Paoli-Calmettes Pancreatic Neoplasms Database NCT02869581 | Institut Paoli-Calmettes | — |
| Completed | Single-centre Propensity Score-matched Comparison of Laparoscopic Versus Open Pancreatoduodenectomy NCT05110573 | General Hospital Groeninge | — |
| Completed | Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer NCT00005648 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 |
| Terminated | Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of Pan NCT00038701 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotox NCT00001805 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pancreatic and Periampullary Tumors in Greenland Inuit NCT05595811 | Rigshospitalet, Denmark | — |
| Completed | A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas NCT00001431 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Me NCT00035035 | Eli Lilly and Company | Phase 3 |
| Withdrawn | Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcin NCT01045941 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 |
| Unknown | Outcome of Pancreatic Stump Closure Following Resection of Tumors of the Head of the Pancreas. NCT00419614 | Hillel Yaffe Medical Center | — |
| Unknown | Aroplatin and Gemcitabine in Patients With Advanced Pancreatic Cancer Resistant to Standard Therapies NCT00081549 | Aronex Pharmaceuticals | Phase 1 / Phase 2 |
| Unknown | A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies NCT00057395 | Aronex Pharmaceuticals | Phase 1 / Phase 2 |